Breakthrough with Animal Vaccine Development
Another breakthrough with Animal Vaccine Development was achieved by VEROVACCiNES GmbH, an accelerator participant and tenant of the Technologiepark Weinberg Campus. As of the 4th of March 2021 VEROVACCiNES GmbH […]
Another breakthrough with Animal Vaccine Development was achieved by VEROVACCiNES GmbH, an accelerator participant and tenant of the Technologiepark Weinberg Campus.
As of the 4th of March 2021 VEROVACCiNES GmbH that participates in the Weinberg Campus Accelerator is able to protect target animals against viral challenges in its 4th Animal Vaccine Program.
Congratulations and keep up the good work.
Read the whole announcement here.
About VEROVACCiNES GmbH
VerovaccinesGmbH is a spin-off of Prof. Dr. Sven-Erik Behrens, Dr. Hanjo Hennemann and Dr. Martina Behrens from the Martin Luther University Halle-Wittenberg, Germany. In addition to the experienced founders, the company has a staff of scientists with expertise in the fields of virology, molecular biology, veterinary medicine and process engineering. Several of the company’s ownvaccine development programs are funded by the “Gründungsoffensive Biotechnologie”, or GO-Bio for short, of the German Federal Ministry of Education and Research (BMBF). (Source: www.verovaccines.org/)
Weinberg Campus Accelerator on Social Media
Events
Latest News
You may also be interested in
Starting a Business: 10 Things You Need to Do
Starting a Business is not an easy undertaking…especially when you have zero experience. Therefore, we made a list of things you need to do to found your own company. So […]
Read More 
How to write a Business Plan: 5 topics you shouldn’t miss
Are you about to start your own company and have already found your Business Idea? If you are still in the process of finding one, then our tips on How […]
Read More 
Business Model: How to master it – Interview with Dr. Merle Fuchs
What do startups have to consider when creating their business model? And how does the process look like to develop it? Dr. Merle Fuchs, could you tell us a little […]
Read More